The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.
  • Ticker

RNS




AstraZeneca PLC - AZN FDA Advisory Committee votes on olaparib
07:00 26-Jun-2014  RNS  0.20% View chart
AstraZeneca PLC - AZN Publication of Prospectus
17:30 24-Jun-2014  RNS  0.20% View chart
AstraZeneca PLC - AZN Clarification of AXA shareholding in AstraZeneca
15:00 13-Jun-2014  RNS  0.20% View chart
AstraZeneca PLC - AZN FDA AdCom recommends no CV trial for PAMORA class
07:00 13-Jun-2014  RNS  0.20% View chart
AstraZeneca PLC - AZN ASTRAZENECA IN-LICENSES SYNAIRGEN'S SNG001
07:00 12-Jun-2014  RNS  0.20% View chart
AstraZeneca PLC - AZN AZ TO PRESENT NEW DATA AT ADA
07:00 11-Jun-2014  RNS  0.20% View chart
AstraZeneca PLC - AZN ASTRAZENECA UPDATES ON ONCOLOGY PIPELINE AT ASCO
14:30 03-Jun-2014  RNS  0.20% View chart
AstraZeneca PLC - AZN STATEMENT REGARDING PFIZER WITHDRAWAL
07:00 27-May-2014  RNS  0.20% View chart
Pfizer Inc - PFZ ANNOUNCEMENT REGARDING ASTRAZENECA PLC
07:00 27-May-2014  RNS  0.00% View chart
AstraZeneca PLC - AZN CLARIFICATION REGARDING PFIZER STATEMENT
18:17 20-May-2014  RNS  0.20% View chart
Pfizer Inc - PFZ Replacement: Final Proposal to AstraZeneca
10:59 20-May-2014  RNS  0.00% View chart
AstraZeneca PLC - AZN ASTRAZENECA BOARD REJECTS PFIZER'S FINAL PROPOSAL
07:08 19-May-2014  RNS  0.20% View chart
Pfizer Inc - PFZ PFIZER MAKES FINAL PROPOSAL TO ASTRAZENECA
07:00 19-May-2014  RNS  0.00% View chart
Morgan Stanley & Co. Int'l plc - 19PK Form 8.5 (EPT/RI) Replacement Astrazeneca Plc
15:46 16-May-2014  RNS  0.00% View chart
AstraZeneca PLC - AZN CONTINUING PROGRESS IN LATE STAGE PIPELINE
13:52 15-May-2014  RNS  0.20% View chart
AstraZeneca PLC - AZN AstraZeneca oncology pipeline update ahead of ASCO
07:00 15-May-2014  RNS  0.20% View chart
AstraZeneca PLC - AZN MedImmune announces immuno-oncology collaboration
07:00 14-May-2014  RNS  0.20% View chart
AstraZeneca PLC - AZN STATEMENT REGARDING PFIZER ANNOUNCEMENT
11:15 13-May-2014  RNS  0.20% View chart
Pfizer Inc - PFZ Replacement: Possible offer for AstraZeneca
10:21 13-May-2014  RNS  0.00% View chart
AstraZeneca PLC - AZN AZ PHASE III SAXA/DAPA RESULTS
07:00 13-May-2014  RNS  0.20% View chart

 Page 1 of 2

| 1 | 2 | Next



RNS - regulatory news service - home


Market News Upgrade

Welcome to the latest upgrade of our Market News section, the definitive place for UK regulatory disclosures.

You will now see:

Enhanced search, filter and sort features giving you the ability to:

  • Include/exclude NAVs & FRNs
  • Exclude all announcements except earnings and news (set as default option)
  • Sort by "Most Read" announcements
  • Search announcements by FTSE index

Additional content such as:

  • Dynamic "Most Read" announcement ticker
  • Greater prominence for company logos
  • Share price change indicator


About RNS

RNS is the London Stock Exchange's regulatory and financial communications channel for companies to communicate with the professional investor.



News Sources

For information about RNS reach and News Announcements, the news sources available within the Market news section.



rssRNS feeds
Allows you to be kept updated with RNS announcements.






The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds